Molecure

📣 We’re happy to inform that #Molecure signed an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors with Nasdaq-listed biotechnology company Ocean Biomedical (OCEA). We are pleased that our early pipeline program has found a partner who sees great potential for further development! 🥳 ➡️ Find out more here: 🇺🇸 https://lnkd.in/dDD3TY_Q 🇵🇱 https://lnkd.in/deRzF9Py Huge thanks and congratulations to everyone who contributed to this achievement! 🎊

We’re excited to participate in the #BIOEurope Conference in Stockholm next week! ✨ During the event, our representatives: CEO Marcin Szumowski, CSO Zbigniew Zaslona and Business Development Manager Maurycy Zieliński, will hold numerous meetings to present our research on #OATD01, #OATD02 and our #mRNA platform 🔬 This is one of the most important events in the biotech industry, offering us a chance to network with industry experts, share knowledge and inspire further innovation in biotechnology 🚀 See you in Sweden! 👋

International collaboration in clinical trials has become increasingly important as new therapies are developed to address global health challenges 🌍 By working across borders, researchers can accelerate the discovery of treatments, increase the diversity of study populations and generate more comprehensive data. Here’s how international collaboration benefits clinical research 👉 International collaboration in clinical trials not only accelerates scientific advancement but also fosters a global community dedicated to improving patient care and public health. This cooperative approach strengthens the reliability and relevance of clinical research, helping to ensure that new treatments are developed efficiently and ethically for the benefit of all 🤝

The 11th #LSBC Central European Life Science Investment Conference has come to an end! ✨ Our CEO, Marcin Szumowski, moderated the panel discussion about the challenges and the influence of AI in drug discovery 💡 A huge thank you to the organizers for an incredible event! It was a fantastic experience, full of knowledge and inspiring insights 🧠 Congratulations to the winners of the Pitch Competition – intoDNA 🧬

🎙 Are you ready for the 11th #LSBC Central European Life Science Investment Conference? Our CEO, Marcin Szumowski, will be moderating Friday’s panel discussion: “Poland’s top company CEOs discuss today’s challenges and the influence of AI”, starting at 12:30 PM ✨ If you're interested in the future of #AI in #lifesciences and #medicine, and want to engage with top industry professionals, don’t miss this opportunity to join us in Kraków! 🚀 #LSBC2024

Ethics committees play a vital role in ensuring that clinical trials are conducted with the highest standards of safety, fairness and ethical responsibility. They operate on various levels and there are either country/national ethics committees or local/hospital committees, also known as Institutional Review Boards (IRBs). Their primary goal is to protect the rights, welfare and dignity of participants involved in research. But how exactly do these committees work? 🤔 Swipe to find out ➡️ In summary, ethics committees serve as a crucial safeguard in clinical trials, ensuring that research is conducted responsibly, transparently and with the utmost respect for participant rights and safety. By upholding these ethical standards, they help build trust in clinical research and ensure that new treatments are developed with integrity 🤝✅

📣 Our focus is on OATD-01 and its breakthrough therapy potential, and progress of OATD-02 trial in patients with solid tumors, which led to reduction of programs in the discovery from five to three.  Key areas for further development and value building for #Molecure are: #OATD01 as a potential breakthrough therapy for the treatment of sarcoidosis and MASH, and #OATD02 in trials in patients with solid tumors. Development of projects in the discovery phase powered by machine learning and generative artificial intelligence (GenAI) methods includes a small-molecule drug discovery platform that modulates #mRNA translational function and the USP7 program. ➡️ For more information click here: https://lnkd.in/ekeFW-QY

#Molecure is pleased to invite you to a meeting to discuss the Company's operational and financial situation after the publication of the Q3 2024 report 🌟   During the meeting, we will present 🔬 progress of ongoing research programs at the clinical and preclinical stages and further plans 📈 The meeting will be held in Polish. The recording in English will be available on October 21st on the Molecure's YouTube channel.   🗓️ Join us on October 16th at 10:00 am (CET)   Registration link: https://lnkd.in/eHuXSMXm  *Registration for the meeting is required - you will receive an email with an individual access link   🔔 The Q3 2024 report is now available on our website. Click here to view the full report (section "Raporty giełdowe") ➡️ https://lnkd.in/djcwrXGn

On World Mental Health Day, let's prioritize our well-being. Mental health is just as important as physical health, and there are many simple steps we can take to nurture it: 🏃♂️ Stay active – regular exercise boosts mood and reduces stress 👥 Connect with others – social support is key for mental well-being. Reach out to family, friends or colleagues and surround yourself with people who care about you 🧘 Practice mindfulness – meditation, deep breathing or just being present can reduce anxiety and improve focus 🌿 Eat well - balanced diet rich in nutrients can support brain health and improve your mood 🛑 Set boundaries – learn to say no and give yourself time to rest and recharge At #Molecure, we believe that supporting mental health is fundamental to living a balanced, fulfilling life 💚

In recent years, innovations in clinical trials have transformed the way we develop new therapies, making the process faster, more efficient and more patient-centered. Here are some of the most exciting advancements that are reshaping clinical research 🚀 👉 Innovations like these are not only making clinical trials more efficient and effective but also improving patient experience and accelerating the development of new, life-saving therapies. As these trends continue to evolve, the future of clinical research holds tremendous potential for advancing healthcare worldwide 🌍